Toll-like receptor 9 (TLR9) agonists have emerged as versatile modulators of innate immunity with the capacity to bridge to adaptive antitumour responses. By engaging endosomal TLR9 on plasmacytoid ...
Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study. ADA2, previously known for its role ...
Jiangsu Hengrui Medicine Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have disclosed Toll-like receptor 7 (TLR7) and/or TLR8 and/or TLR9 antagonists reported to be useful for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results